APO Research
Talk to an analyst

APO RESEARCH · REPORT

Travelers Vaccines

A vaccine is a biological preparation that improves immunity to a particular disease. A vaccine typically contains an agent that resembles a disease-causing microorganism, and is often made from weakened or killed forms of the microbe, its toxins or one of its surface proteins. The agent stimulates the body's immune system to recognize the agent as foreign, destroy it, and "remember" it, so that the immune system can more easily recognize and destroy any of these microorganisms that it later encounters.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

A vaccine is a biological preparation that improves immunity to a particular disease. A vaccine typically contains an agent that resembles a disease-causing microorganism, and is often made from weakened or killed forms of the microbe, its toxins or one of its surface proteins. The agent stimulates the body's immune system to recognize the agent as foreign, destroy it, and "remember" it, so that the immune system can more easily recognize and destroy any of these microorganisms that it later encounters.

Travelers are at increased risk for several infections, including familiar infections such as measles that are widely distributed but more common in developing countries. Travelers Vaccines can markedly decrease the risk for many of these infections and are an important part of pretravel preparation.

In this report, the travelers vaccines mainly covers vaccine for hepatitis A, hepatitis B, rabies, typhoid fever, yellow fever, Japanese encephalitis, meningococcal meningitis, cholera, etc.

Selected research

Market Outlook & Growth Opportunities

Global Travelers Vaccines Market Outlook and Growth Opportunities 2026

21 December 2025195 pages

Choose your research edition.

Industry ResearchTravelers Vaccines Industry Research Report 2026122 pages · $2,950 USDIndustry Growth & TrendsGlobal Travelers Vaccines Industry Growth and Trends Forecast to 203298 pages · $3,450 USDMarket StructureGlobal Travelers Vaccines Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032184 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Travelers Vaccines Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Travelers Vaccines Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

A vaccine is a biological preparation that improves immunity to a particular disease. A vaccine typically contains an agent that resembles a disease-causing microorganism, and is often made from weakened or killed forms of the microbe, its toxins or one of its surface proteins. The agent stimulates the body's immune system to recognize the agent as foreign, destroy it, and "remember" it, so that the immune system can more easily recognize and destroy any of these microorganisms that it later encounters.

Travelers are at increased risk for several infections, including familiar infections such as measles that are widely distributed but more common in developing countries. Travelers Vaccines can markedly decrease the risk for many of these infections and are an important part of pretravel preparation.

In this report, the travelers vaccines mainly covers vaccine for hepatitis A, hepatitis B, rabies, typhoid fever, yellow fever, Japanese encephalitis, meningococcal meningitis, cholera, etc.

Read the full market overview

Merck, GlaxoSmithKline and Sanofi Pasteur are the main manufacturers in the vaccine market, with a market share of more than 60% and a high degree of market concentration. North America and Europe are the main production regions, with market share of more than 40% and 30%.

This report provides an overview of the global Travelers Vaccines market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Travelers Vaccines and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Travelers Vaccines sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Travelers Vaccines market size, projected growth trends, production technologies, key applications, and end-use industries.

Travelers Vaccines Segment by Company

GlaxoSmithKline

Sanofi Pasteur

Merck

Pfizer

CNBG

Sanofi Pasteur MSD

Serum Institute of India

Biokangtai

Travelers Vaccines Segment by Type

Meningococcal Vaccine

Japanese Encephalitis Vaccine

Yellow Fever Vaccine

Hepatitis Vaccine

Cholera Vaccine

Other

Travelers Vaccines Segment by End Users

Tourists

Students

Workers

Others

Travelers Vaccines Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Travelers Vaccines status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Travelers Vaccines market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Travelers Vaccines significant trends, drivers, influence factors in global and regions.

6. To analyze Travelers Vaccines competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Travelers Vaccines market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Travelers Vaccines and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Travelers Vaccines.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Travelers Vaccines market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Travelers Vaccines industry.

Chapter 3: Detailed analysis of Travelers Vaccines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Travelers Vaccines in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Travelers Vaccines in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Travelers Vaccines Industry Trends Table 2. Travelers Vaccines Industry Drivers Table 3. Travelers Vaccines Industry Opportunities and Challenges Table 4. Travelers Vaccines Industry Restraints Table 5. Global Travelers Vaccines Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Travelers Vaccines Revenue Share by Company (2021-2026) Table 7. Global Travelers Vaccines Sales Volume by Company (k doses) & (2021-2026) Table 8. Global Travelers Vaccines Sales Volume Share by Company (2021-2026) Table 9. Global Travelers Vaccines Average Price (USD/dose) of Company (2021-2026) Table 10. Global Travelers Vaccines Company Ranking, (2024-2026) & (USD Million) Table 11. Global Travelers Vaccines Key Company Manufacturing Base & Headquarters Table 12. Global Travelers Vaccines Company, Product Type & Application Table 13. Global Travelers Vaccines Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Travelers Vaccines by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Meningococcal Vaccine Table 18. Significant Companies of Japanese Encephalitis Vaccine Table 19. Significant Companies of Yellow Fever Vaccine Table 20. Significant Companies of Hepatitis Vaccine Table 21. Significant Companies of Cholera Vaccine Table 22. Significant Companies of Other Table 23. Global Travelers Vaccines Sales Volume by Type 2021 VS 2025 VS 2032 (k doses) Table 24. Global Travelers Vaccines Sales Volume by Type (2021-2026) & (k doses) Table 25. Global Travelers Vaccines Sales Volume by Type (2027-2032) & (k doses) Table 26. Global Travelers Vaccines Sales Volume Share by Type (2021-2026) Table 27. Global Travelers Vaccines Sales Volume Share by Type (2027-2032) Table 28. Global Travelers Vaccines Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 29. Global Travelers Vaccines Sales Value by Type (2021-2026) & (US$ Million) Table 30. Global Travelers Vaccines Sales Value by Type (2027-2032) & (US$ Million) Table 31. Global Travelers Vaccines Sales Value Share by Type (2021-2026) Table 32. Global Travelers Vaccines Sales Value Share by Type (2027-2032) Table 33. Significant Companies of Tourists Table 34. Significant Companies of Students Table 35. Significant Companies of Workers Table 36. Significant Companies of Others Table 37. Global Travelers Vaccines Sales Volume by Application 2021 VS 2025 VS 2032 (k doses) Table 38. Global Travelers Vaccines Sales Volume by Application (2021-2026) & (k doses) Table 39. Global Travelers Vaccines Sales Volume by Application (2027-2032) & (k doses) Table 40. Global Travelers Vaccines Sales Volume Share by Application (2021-2026) Table 41. Global Travelers Vaccines Sales Volume Share by Application (2027-2032) Table 42. Global Travelers Vaccines Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 43. Global Travelers Vaccines Sales Value by Application (2021-2026) & (US$ Million) Table 44. Global Travelers Vaccines Sales Value by Application (2027-2032) & (US$ Million) Table 45. Global Travelers Vaccines Sales Value Share by Application (2021-2026) Table 46. Global Travelers Vaccines Sales Value Share by Application (2027-2032) Table 47. Global Travelers Vaccines Sales by Region: 2021 VS 2025 VS 2032 (k doses) Table 48. Global Travelers Vaccines Sales by Region (2021-2026) & (k doses) Table 49. Global Travelers Vaccines Sales Market Share by Region (2021-2026) Table 50. Global Travelers Vaccines Sales by Region (2027-2032) & (k doses) Table 51. Global Travelers Vaccines Sales Market Share by Region (2027-2032) Table 52. Global Travelers Vaccines Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 53. Global Travelers Vaccines Sales Value by Region (2021-2026) & (US$ Million) Table 54. Global Travelers Vaccines Sales Value Share by Region (2021-2026) Table 55. Global Travelers Vaccines Sales Value by Region (2027-2032) & (US$ Million) Table 56. Global Travelers Vaccines Sales Value Share by Region (2027-2032) Table 57. Global Travelers Vaccines Market Average Price (USD/dose) by Region (2021-2026) Table 58. Global Travelers Vaccines Market Average Price (USD/dose) by Region (2027-2032) Table 59. Global Travelers Vaccines Sales by Country: 2021 VS 2025 VS 2032 (k doses) Table 60. Global Travelers Vaccines Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 61. Global Travelers Vaccines Sales by Country (2021-2026) & (k doses) Table 62. Global Travelers Vaccines Sales Market Share by Country (2021-2026) Table 63. Global Travelers Vaccines Sales by Country (2027-2032) & (k doses) Table 64. Global Travelers Vaccines Sales Market Share by Country (2027-2032) Table 65. Global Travelers Vaccines Sales Value by Country (2021-2026) & (US$ Million) Table 66. Global Travelers Vaccines Sales Value Market Share by Country (2021-2026) Table 67. Global Travelers Vaccines Sales Value by Country (2027-2032) & (US$ Million) Table 68. Global Travelers Vaccines Sales Value Market Share by Country (2027-2032) Table 69. GlaxoSmithKline Company Information Table 70. GlaxoSmithKline Business Overview Table 71. GlaxoSmithKline Travelers Vaccines Sales (k doses), Value (US$ Million), Price (USD/dose) and Gross Margin (2021-2026) Table 72. GlaxoSmithKline Travelers Vaccines Product Portfolio Table 73. GlaxoSmithKline Recent Development Table 74. Sanofi Pasteur Company Information Table 75. Sanofi Pasteur Business Overview Table 76. Sanofi Pasteur Travelers Vaccines Sales (k doses), Value (US$ Million), Price (USD/dose) and Gross Margin (2021-2026) Table 77. Sanofi Pasteur Travelers Vaccines Product Portfolio Table 78. Sanofi Pasteur Recent Development Table 79. Merck Company Information Table 80. Merck Business Overview Table 81. Merck Travelers Vaccines Sales (k doses), Value (US$ Million), Price (USD/dose) and Gross Margin (2021-2026) Table 82. Merck Travelers Vaccines Product Portfolio Table 83. Merck Recent Development Table 84. Pfizer Company Information Table 85. Pfizer Business Overview Table 86. Pfizer Travelers Vaccines Sales (k doses), Value (US$ Million), Price (USD/dose) and Gross Margin (2021-2026) Table 87. Pfizer Travelers Vaccines Product Portfolio Table 88. Pfizer Recent Development Table 89. CNBG Company Information Table 90. CNBG Business Overview Table 91. CNBG Travelers Vaccines Sales (k doses), Value (US$ Million), Price (USD/dose) and Gross Margin (2021-2026) Table 92. CNBG Travelers Vaccines Product Portfolio Table 93. CNBG Recent Development Table 94. Sanofi Pasteur MSD Company Information Table 95. Sanofi Pasteur MSD Business Overview Table 96. Sanofi Pasteur MSD Travelers Vaccines Sales (k doses), Value (US$ Million), Price (USD/dose) and Gross Margin (2021-2026) Table 97. Sanofi Pasteur MSD Travelers Vaccines Product Portfolio Table 98. Sanofi Pasteur MSD Recent Development Table 99. Serum Institute of India Company Information Table 100. Serum Institute of India Business Overview Table 101. Serum Institute of India Travelers Vaccines Sales (k doses), Value (US$ Million), Price (USD/dose) and Gross Margin (2021-2026) Table 102. Serum Institute of India Travelers Vaccines Product Portfolio Table 103. Serum Institute of India Recent Development Table 104. Biokangtai Company Information Table 105. Biokangtai Business Overview Table 106. Biokangtai Travelers Vaccines Sales (k doses), Value (US$ Million), Price (USD/dose) and Gross Margin (2021-2026) Table 107. Biokangtai Travelers Vaccines Product Portfolio Table 108. Biokangtai Recent Development Table 109. Key Raw Materials Table 110. Raw Materials Key Suppliers Table 111. Travelers Vaccines Distributors List Table 112. Travelers Vaccines Customers List Table 113. Research Programs/Design for This Report Table 114. Authors List of This Report Table 115. Secondary Sources Table 116. Primary Sources List of Figures Figure 1. Travelers Vaccines Product Image Figure 2. Global Travelers Vaccines Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Travelers Vaccines Sales Value (2021-2032) & (US$ Million) Figure 4. Global Travelers Vaccines Sales (2021-2032) & (k doses) Figure 5. Global Travelers Vaccines Sales Average Price (USD/dose) & (2021-2032) Figure 6. Global Travelers Vaccines Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Meningococcal Vaccine Image Figure 10. Japanese Encephalitis Vaccine Image Figure 11. Yellow Fever Vaccine Image Figure 12. Hepatitis Vaccine Image Figure 13. Cholera Vaccine Image Figure 14. Other Image Figure 15. Global Travelers Vaccines Sales Volume by Type (2021 VS 2025 VS 2032) & (k doses) Figure 16. Global Travelers Vaccines Sales Volume Share 2021 VS 2025 VS 2032 Figure 17. Global Travelers Vaccines Sales Volume Share by Type (2021-2032) Figure 18. Global Travelers Vaccines Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 19. Global Travelers Vaccines Sales Value Share 2021 VS 2025 VS 2032 Figure 20. Global Travelers Vaccines Sales Value Share by Type (2021-2032) Figure 21. Tourists Image Figure 22. Students Image Figure 23. Workers Image Figure 24. Others Image Figure 25. Global Travelers Vaccines Sales Volume by Application (2021 VS 2025 VS 2032) & (k doses) Figure 26. Global Travelers Vaccines Sales Volume Share 2021 VS 2025 VS 2032 Figure 27. Global Travelers Vaccines Sales Volume Share by Application (2021-2032) Figure 28. Global Travelers Vaccines Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 29. Global Travelers Vaccines Sales Value Share 2021 VS 2025 VS 2032 Figure 30. Global Travelers Vaccines Sales Value Share by Application (2021-2032) Figure 31. Global Travelers Vaccines Sales by Region: 2021 VS 2025 VS 2032 (k doses) Figure 32. Global Travelers Vaccines Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 33. Global Travelers Vaccines Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 34. Global Travelers Vaccines Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 35. North America Travelers Vaccines Sales Value (2021-2032) & (US$ Million) Figure 36. North America Travelers Vaccines Sales Value Share by Country (%), 2025 VS 2032 Figure 37. Europe Travelers Vaccines Sales Value (2021-2032) & (US$ Million) Figure 38. Europe Travelers Vaccines Sales Value Share by Country (%), 2025 VS 2032 Figure 39. Asia-Pacific Travelers Vaccines Sales Value (2021-2032) & (US$ Million) Figure 40. Asia-Pacific Travelers Vaccines Sales Value Share by Country (%), 2025 VS 2032 Figure 41. South America Travelers Vaccines Sales Value (2021-2032) & (US$ Million) Figure 42. South America Travelers Vaccines Sales Value Share by Country (%), 2025 VS 2032 Figure 43. Middle East & Africa Travelers Vaccines Sales Value (2021-2032) & (US$ Million) Figure 44. Middle East & Africa Travelers Vaccines Sales Value Share by Country (%), 2025 VS 2032 Figure 45. USA Travelers Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. USA Travelers Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. USA Travelers Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Canada Travelers Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Canada Travelers Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Canada Travelers Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Mexico Travelers Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Mexico Travelers Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Mexico Travelers Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. Germany Travelers Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. Germany Travelers Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. Germany Travelers Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. France Travelers Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. France Travelers Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. France Travelers Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. U.K. Travelers Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. U.K. Travelers Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. U.K. Travelers Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Italy Travelers Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Italy Travelers Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Italy Travelers Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Spain Travelers Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Spain Travelers Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Spain Travelers Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Russia Travelers Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Russia Travelers Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Russia Travelers Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. Netherlands Travelers Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. Netherlands Travelers Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. Netherlands Travelers Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. Nordic Countries Travelers Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. Nordic Countries Travelers Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. Nordic Countries Travelers Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. China Travelers Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. China Travelers Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. China Travelers Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. Japan Travelers Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. Japan Travelers Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. Japan Travelers Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. South Korea Travelers Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. South Korea Travelers Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. South Korea Travelers Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. India Travelers Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. India Travelers Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. India Travelers Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Australia Travelers Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Australia Travelers Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Australia Travelers Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Southeast Asia Travelers Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Southeast Asia Travelers Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Southeast Asia Travelers Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Brazil Travelers Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Brazil Travelers Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Brazil Travelers Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Argentina Travelers Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Argentina Travelers Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Argentina Travelers Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Chile Travelers Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Chile Travelers Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Chile Travelers Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Colombia Travelers Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Colombia Travelers Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Colombia Travelers Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Peru Travelers Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Peru Travelers Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Peru Travelers Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Saudi Arabia Travelers Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Saudi Arabia Travelers Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Saudi Arabia Travelers Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Israel Travelers Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. Israel Arabia Travelers Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. Israel Arabia Travelers Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. UAE Travelers Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 118. UAE Travelers Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 119. UAE Travelers Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 120. Turkey Travelers Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 121. Turkey Travelers Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 122. Turkey Travelers Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 123. Iran Travelers Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 124. Iran Travelers Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 125. Iran Travelers Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 126. Egypt Travelers Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 127. Egypt Travelers Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 128. Egypt Travelers Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 129. Travelers Vaccines Value Chain Figure 130. Manufacturing Cost Structure Figure 131. Travelers Vaccines Sales Mode & Process Figure 132. Direct Comparison with Distribution Share Figure 133. Distributors Profiles Figure 134. Years Considered Figure 135. Research Process Figure 136. Key Executives Interviewed

Scope & coverage.

Types
  • Meningococcal Vaccine
  • Japanese Encephalitis Vaccine
  • Yellow Fever Vaccine
  • Hepatitis Vaccine
  • Cholera Vaccine
  • Other
Applications
  • Tourists
  • Students
  • Workers
  • Others
Companies covered
  • GlaxoSmithKline
  • Sanofi Pasteur
  • Merck
  • Pfizer
  • CNBG
  • Sanofi Pasteur MSD
  • Serum Institute of India
  • Biokangtai

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Travelers Vaccines Sales Value (2021-2032)
  4. 1.2.2 Global Travelers Vaccines Sales Volume (2021-2032)
  5. 1.2.3 Global Travelers Vaccines Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Travelers Vaccines Market Dynamics
  1. 2.1 Travelers Vaccines Industry Trends
  2. 2.2 Travelers Vaccines Industry Drivers
  3. 2.3 Travelers Vaccines Industry Opportunities and Challenges
  4. 2.4 Travelers Vaccines Industry Restraints
3 Travelers Vaccines Market by Company
  1. 3.1 Global Travelers Vaccines Company Revenue Ranking in 2025
  2. 3.2 Global Travelers Vaccines Revenue by Company (2021-2026)
  3. 3.3 Global Travelers Vaccines Sales Volume by Company (2021-2026)
  4. 3.4 Global Travelers Vaccines Average Price by Company (2021-2026)
  5. 3.5 Global Travelers Vaccines Company Ranking (2024-2026)
  6. 3.6 Global Travelers Vaccines Company Manufacturing Base and Headquarters
  7. 3.7 Global Travelers Vaccines Company Product Type and Application
  8. 3.8 Global Travelers Vaccines Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Travelers Vaccines Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Travelers Vaccines Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Travelers Vaccines Market by Type
  1. 4.1 Travelers Vaccines Type Introduction
  2. 4.1.1 Meningococcal Vaccine
  3. 4.1.2 Japanese Encephalitis Vaccine
  4. 4.1.3 Yellow Fever Vaccine
  5. 4.1.4 Hepatitis Vaccine
  6. 4.1.5 Cholera Vaccine
  7. 4.1.6 Other
  8. 4.2 Global Travelers Vaccines Sales Volume by Type
  9. 4.2.1 Global Travelers Vaccines Sales Volume by Type (2021 VS 2025 VS 2032)
  10. 4.2.2 Global Travelers Vaccines Sales Volume by Type (2021-2032)
  11. 4.2.3 Global Travelers Vaccines Sales Volume Share by Type (2021-2032)
  12. 4.3 Global Travelers Vaccines Sales Value by Type
  13. 4.3.1 Global Travelers Vaccines Sales Value by Type (2021 VS 2025 VS 2032)
  14. 4.3.2 Global Travelers Vaccines Sales Value by Type (2021-2032)
  15. 4.3.3 Global Travelers Vaccines Sales Value Share by Type (2021-2032)
5 Travelers Vaccines Market by Application
  1. 5.1 Travelers Vaccines Application Introduction
  2. 5.1.1 Tourists
  3. 5.1.2 Students
  4. 5.1.3 Workers
  5. 5.1.4 Others
  6. 5.2 Global Travelers Vaccines Sales Volume by Application
  7. 5.2.1 Global Travelers Vaccines Sales Volume by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Travelers Vaccines Sales Volume by Application (2021-2032)
  9. 5.2.3 Global Travelers Vaccines Sales Volume Share by Application (2021-2032)
  10. 5.3 Global Travelers Vaccines Sales Value by Application
  11. 5.3.1 Global Travelers Vaccines Sales Value by Application (2021 VS 2025 VS 2032)
  12. 5.3.2 Global Travelers Vaccines Sales Value by Application (2021-2032)
  13. 5.3.3 Global Travelers Vaccines Sales Value Share by Application (2021-2032)
6 Travelers Vaccines Regional Sales and Value Analysis
  1. 6.1 Global Travelers Vaccines Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Travelers Vaccines Sales by Region (2021-2032)
  3. 6.2.1 Global Travelers Vaccines Sales by Region: 2021-2026
  4. 6.2.2 Global Travelers Vaccines Sales by Region (2027-2032)
  5. 6.3 Global Travelers Vaccines Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Travelers Vaccines Sales Value by Region (2021-2032)
  7. 6.4.1 Global Travelers Vaccines Sales Value by Region: 2021-2026
  8. 6.4.2 Global Travelers Vaccines Sales Value by Region (2027-2032)
  9. 6.5 Global Travelers Vaccines Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Travelers Vaccines Sales Value (2021-2032)
  12. 6.6.2 North America Travelers Vaccines Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Travelers Vaccines Sales Value (2021-2032)
  15. 6.7.2 Europe Travelers Vaccines Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Travelers Vaccines Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Travelers Vaccines Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Travelers Vaccines Sales Value (2021-2032)
  21. 6.9.2 South America Travelers Vaccines Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Travelers Vaccines Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Travelers Vaccines Sales Value Share by Country, 2025 VS 2032
7 Travelers Vaccines Country-level Sales and Value Analysis
  1. 7.1 Global Travelers Vaccines Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Travelers Vaccines Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Travelers Vaccines Sales by Country (2021-2032)
  4. 7.3.1 Global Travelers Vaccines Sales by Country (2021-2026)
  5. 7.3.2 Global Travelers Vaccines Sales by Country (2027-2032)
  6. 7.4 Global Travelers Vaccines Sales Value by Country (2021-2032)
  7. 7.4.1 Global Travelers Vaccines Sales Value by Country (2021-2026)
  8. 7.4.2 Global Travelers Vaccines Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Travelers Vaccines Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Travelers Vaccines Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Travelers Vaccines Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Travelers Vaccines Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Travelers Vaccines Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Travelers Vaccines Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Travelers Vaccines Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Travelers Vaccines Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Travelers Vaccines Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Travelers Vaccines Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Travelers Vaccines Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Travelers Vaccines Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Travelers Vaccines Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Travelers Vaccines Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Travelers Vaccines Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Travelers Vaccines Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Travelers Vaccines Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Travelers Vaccines Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Travelers Vaccines Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Travelers Vaccines Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Travelers Vaccines Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Travelers Vaccines Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Travelers Vaccines Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Travelers Vaccines Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Travelers Vaccines Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Travelers Vaccines Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Travelers Vaccines Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Travelers Vaccines Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Travelers Vaccines Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Travelers Vaccines Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Travelers Vaccines Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Travelers Vaccines Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Travelers Vaccines Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Travelers Vaccines Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Travelers Vaccines Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Travelers Vaccines Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Travelers Vaccines Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Travelers Vaccines Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Travelers Vaccines Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Travelers Vaccines Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Travelers Vaccines Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Travelers Vaccines Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Travelers Vaccines Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Travelers Vaccines Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Travelers Vaccines Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Travelers Vaccines Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Travelers Vaccines Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Travelers Vaccines Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Travelers Vaccines Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Travelers Vaccines Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Travelers Vaccines Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Travelers Vaccines Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Travelers Vaccines Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Travelers Vaccines Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Travelers Vaccines Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Travelers Vaccines Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Travelers Vaccines Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Travelers Vaccines Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Travelers Vaccines Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Travelers Vaccines Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Travelers Vaccines Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Travelers Vaccines Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Travelers Vaccines Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Travelers Vaccines Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Travelers Vaccines Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Travelers Vaccines Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Travelers Vaccines Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Travelers Vaccines Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Travelers Vaccines Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Travelers Vaccines Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Travelers Vaccines Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Travelers Vaccines Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Travelers Vaccines Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Travelers Vaccines Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Travelers Vaccines Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Travelers Vaccines Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Travelers Vaccines Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Travelers Vaccines Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Travelers Vaccines Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Travelers Vaccines Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Travelers Vaccines Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Travelers Vaccines Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Travelers Vaccines Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Travelers Vaccines Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 GlaxoSmithKline
  2. 8.1.1 GlaxoSmithKline Company Information
  3. 8.1.2 GlaxoSmithKline Business Overview
  4. 8.1.3 GlaxoSmithKline Travelers Vaccines Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 GlaxoSmithKline Travelers Vaccines Product Portfolio
  6. 8.1.5 GlaxoSmithKline Recent Developments
  7. 8.2 Sanofi Pasteur
  8. 8.2.1 Sanofi Pasteur Company Information
  9. 8.2.2 Sanofi Pasteur Business Overview
  10. 8.2.3 Sanofi Pasteur Travelers Vaccines Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Sanofi Pasteur Travelers Vaccines Product Portfolio
  12. 8.2.5 Sanofi Pasteur Recent Developments
  13. 8.3 Merck
  14. 8.3.1 Merck Company Information
  15. 8.3.2 Merck Business Overview
  16. 8.3.3 Merck Travelers Vaccines Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Merck Travelers Vaccines Product Portfolio
  18. 8.3.5 Merck Recent Developments
  19. 8.4 Pfizer
  20. 8.4.1 Pfizer Company Information
  21. 8.4.2 Pfizer Business Overview
  22. 8.4.3 Pfizer Travelers Vaccines Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Pfizer Travelers Vaccines Product Portfolio
  24. 8.4.5 Pfizer Recent Developments
  25. 8.5 CNBG
  26. 8.5.1 CNBG Company Information
  27. 8.5.2 CNBG Business Overview
  28. 8.5.3 CNBG Travelers Vaccines Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 CNBG Travelers Vaccines Product Portfolio
  30. 8.5.5 CNBG Recent Developments
  31. 8.6 Sanofi Pasteur MSD
  32. 8.6.1 Sanofi Pasteur MSD Company Information
  33. 8.6.2 Sanofi Pasteur MSD Business Overview
  34. 8.6.3 Sanofi Pasteur MSD Travelers Vaccines Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Sanofi Pasteur MSD Travelers Vaccines Product Portfolio
  36. 8.6.5 Sanofi Pasteur MSD Recent Developments
  37. 8.7 Serum Institute of India
  38. 8.7.1 Serum Institute of India Company Information
  39. 8.7.2 Serum Institute of India Business Overview
  40. 8.7.3 Serum Institute of India Travelers Vaccines Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Serum Institute of India Travelers Vaccines Product Portfolio
  42. 8.7.5 Serum Institute of India Recent Developments
  43. 8.8 Biokangtai
  44. 8.8.1 Biokangtai Company Information
  45. 8.8.2 Biokangtai Business Overview
  46. 8.8.3 Biokangtai Travelers Vaccines Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Biokangtai Travelers Vaccines Product Portfolio
  48. 8.8.5 Biokangtai Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Travelers Vaccines Value Chain Analysis
  2. 9.1.1 Travelers Vaccines Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Travelers Vaccines Sales Mode & Process
  6. 9.2 Travelers Vaccines Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Travelers Vaccines Distributors
  9. 9.2.3 Travelers Vaccines Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst